Caraway Therapeutics

Caraway Therapeutics is a company that discovers drugs for neurodegenerative diseases. It uses genetic data and biology to develop small molecules that activate neurons’ clearance and recycling processes – accelerating removal of toxic materials and defective cellular components. The company aims to provide disease-modifying compounds for patients suffering from Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and lysosomal storage diseases.